American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™ (5th Ed.). Arlington, VA, US: American Psychiatric Publishing, Inc.; 2013.
Timimi S. Non-diagnostic based approaches to helping children who could be labelled ADHD and their families. Int J Qual Stud Health Well-being 2017;12(sup1):1298270.
Gonon F, Konsman J, Cohen D, Boraud T, Boutron I. Why most biomedical findings echoed by newspapers turn out to be false: The case of attention deficit hyperactivity disorder. PLoS One 2012;7(9):1-11.
Ponnou S, Gonon F. How French media have portrayed ADHD to the lay public and to social workers. Int J Qual Stud Health Well-being 2017;12(sup1):1298244
Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry 2017;4(4):310-9.
Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ 2015;351:h5203.
Swanson JM, Arnold LE, Molina BS, Sibley MH, Hechtman LT, Hinshaw SP, et al. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry 2017;58(6):663-78.
Batstra L, Nieweg EH, Hadders-Algra M. Exploring five common assumptions on attention deficit hyperactivity disorder. Acta Paediatr 2014;103(7):696-700.
Dehue T, Bijl D, de Winter M, Scheepers F, Vanheule S, van Os J, et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults. Lancet Psychiatry 2017;4(6):438-9.
Johnston C, Mash EJ. Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clin Child Fam Psychol Rev 2001;4(3):183-207.
Hjern A, Weitoft GR, Lindblad F. Social adversity predicts ADHD-medication in school children--a national cohort study. Acta Paediatr 2010;99(6):920-4.
Russell AE, Ford T, Williams R, Russell G. The association between socioeconomic disadvantage and attention deficit/hyperactivity disorder (ADHD): a systematic review. Child Psychiatry Hum Dev 2016;47(3):440-58.
Health Council of the Netherlands. ADHD: Medication and society. The Hague: Health Council of the Netherlands 2014. Available from https://www.healthcouncil.nl
Fabiano GA, Pelham WE, jr Coles EK, Gnagy EM, Chronis-Tuscano A, O’Connor BC. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev 2009;29(2):129-40.
Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder–first upgrade. Eur Child Adolesc Psychiatry 2004;13(1): i7-i30.
Barkley RA. Recent longitudinal studies of childhood attention-deficit/hyperactivity disorder: Important themes and questions for further research. J Abnorm Psychol 2016;125(2):248-55.
Corrigan MW and Whitaker. Lancet Psychiatry Needs to Retract the ADHD-Enigma Study. Mad in America 2017. Available from: https://www.madinamerica.com/2017/04/lancet-psychiatry-needs-to-retract-the-adhd-enigma-study/
Holmskov M, Storebø OJ, Moreira-Maia CR, Ramstad E, Magnusson FL, Krogh HB, et al. Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials. PloS One 2017;12(6):e0178187.
Sonuga-Barke EJ, Auerbach J, Campbell SB, Daley D, Thompson M. Varieties of preschool hyperactivity: multiple pathways from risk to disorder. Dev Sci 2005;8(2):141-50.
Pauli-Pott U, Schloss S, Heinzel-Gutenbrunner M, Becker K. Multiple causal pathways in attention-deficit/hyperactivity disorder - Do emerging executive and motivational deviations precede symptom development? Child Neuropsychol 2019;25(2):179-97.
Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, et al. Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine. CNS Drugs 2017;31(3):199-215.
MTA cooperative group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 1999;56(12):1073-86.
Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, et al. 3-Year Follow-up of the NIMH MTA Study. J Am Acad Child Adolesc Psychiatry 2007;46(8):989-1002.
Nieweg EH. [Does ADHD medication stop working after 2-3 years? On the surprising, but little-known follow-up of the MTA study]. Tijdschrift Voor Psychiatrie 2010;52(4):245-54.
Whitely M, Raven M, Timimi S, Jureidini J, Phillimore J, Leo J, et al. Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: a systematic review. J Child Psychol Psychiatry 2019;60(4):380–91.
te Meerman S, Batstra L, Hoekstra R, Grietens H. Academic textbooks on ADHD genetics: balanced or biased? Int J Qual Stud Health Well-Being 2017;12(sup1):1305590.
Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 2012;109(4):1193-8.
te Meerman S, Batstra L, Grietens H, Frances A. ADHD: a critical update for educational professionals. Int J Qual Stud Health Well-Being 2017b;12(sup1):1298267.